0.06 - 0.07
0.06 - 0.24
1.89M / 3.59M (Avg.)
-1.60 | -0.04
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
43.03%
Positive EBIT growth while NHC.AX is negative. John Neff might see a substantial edge in operational management.
43.03%
Operating income growth above 1.5x NHC.AX's 15.63%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
98.33%
Net income growth above 1.5x NHC.AX's 51.80%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
98.37%
EPS growth above 1.5x NHC.AX's 40.74%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
98.37%
Diluted EPS growth above 1.5x NHC.AX's 46.15%. David Dodd would see if there's a robust moat protecting these shareholder gains.
4.91%
Share count expansion well above NHC.AX's 5.11%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
4.91%
Diluted share count expanding well above NHC.AX's 6.15%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
59.77%
Positive OCF growth while NHC.AX is negative. John Neff would see this as a clear operational advantage vs. the competitor.
58.01%
Positive FCF growth while NHC.AX is negative. John Neff would see a strong competitive edge in net cash generation.
-100.00%
Negative 10Y revenue/share CAGR while NHC.AX stands at 249.37%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-100.00%
Negative 5Y CAGR while NHC.AX stands at 53.81%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-100.00%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
51.86%
10Y OCF/share CAGR under 50% of NHC.AX's 355.06%. Michael Burry would worry about a persistent underperformance in cash creation.
51.86%
Below 50% of NHC.AX's 141.95%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
51.86%
Positive 3Y OCF/share CAGR while NHC.AX is negative. John Neff might see a big short-term edge in operational efficiency.
98.82%
Below 50% of NHC.AX's 1467.85%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
98.82%
Below 50% of NHC.AX's 356.47%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
98.82%
Positive short-term CAGR while NHC.AX is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
18.76%
Asset growth above 1.5x NHC.AX's 1.97%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-1.39%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-73.75%
We cut SG&A while NHC.AX invests at 18.38%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.